Economics (e.g. cost-effectiveness)

Ernst, D., Petrella, T., Joshua, A., Hamou, A., Thabane, M., Vantyghem, S., & Gwadry-Sridhar, F. (2016). Burden of illness for metastatic melanoma in Canada, 2011–2013. Current Oncology, 23(6), e563-e570 (Abstract)

Hiligsmann M, Salas M, Hughes D, Manias E, Gwadry-Sridhar F, Cowell W. Cost to society due to underemployment in persons with Hemophilia A and B – Hemophilia Utilization Group Study (HUGS V). ISPOR 18th Annual International Meeting Research Poster Presentations – Session II, May 2013; 16(3): A119–A120 (Abstract)

Poon JL, Zhou ZY, Doctor JWU, Ullman MM, Ross C, Riske B, Parish KL, Lou M, Koerper M, Gwadry-Sridhar F, Forsberg AD, Curtis RG, Johnson KA. Quality of Life in Haemophilia A: Hemophilia Utilization Group Study Va (HUGS-Va). Haemophilia. 2012 Sep; 18(5):699-707. (Abstract)

Lou M, Zhou ZY, Gwadry-Sridhar F, Poon JL, Doctor J, Koerper M, Ullman M, Johnson K. Utilizing a Paper Standard Gamble Instrument to Assess Health Utility in Patients with Hemophilia B. Value in Health. May 2011; 14(3): A208, PND33, 2011. (Abstract)

Sridhar K, Gwadry-Sridhar F. Clinical outcomes and Costs of Drug Eluting Stents in the Cardiac Catherization Lab. Value in Health. 2003; 6(6), CV8. (Abstract)

Gwadry-Sridhar F, Arnold M, Weaver B, Guyatt G. Does Compliance with ACE-I, Digoxin and Spironolactone Influence the Time to Event in Patients with Heart Failure. Value in Health. 2002; 5(6), PCV37. (Abstract)

Niu X, Poon JL, Lou M, Ullman M, Koerper M, Baker J, Hord J, Konkle BA, Riske B, Buranahirun C, Gwadry-Sridhar F, Curtis RG, Kulkami R, Soni A, Nichol M. Burden of Bleeding Episodes Among Persons with Hemophilia B. NHF 65th Annual Meeting. Anaheim, CA. 2013 (Poster)